BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18167272)

  • 1. [Human mucin 1 promoter drives human sodium/iodide symporter gene targeting expression in pancreatic carcinoma cells].
    Zhou QB; Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Chen JS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2780-4. PubMed ID: 18167272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
    Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
    Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
    Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W; Tan J; Wang P; Wu P
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
    Kim YH; Youn H; Na J; Hong KJ; Kang KW; Lee DS; Chung JK
    Theranostics; 2015; 5(1):86-96. PubMed ID: 25553100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.
    Kim YH; Lee DS; Kang JH; Lee YJ; Chung JK; Roh JK; Kim SU; Lee MC
    J Nucl Med; 2005 Feb; 46(2):305-11. PubMed ID: 15695791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
    Smit JW; Shröder-van der Elst JP; Karperien M; Que I; van der Pluijm G; Goslings B; Romijn JA; van der Heide D
    Thyroid; 2000 Nov; 10(11):939-43. PubMed ID: 11128720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
    Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
    Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
    Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.
    Chai W; Yin X; Ren L; Cai M; Long T; Zhou M; Tang Y; Yang N; Hu S
    Clin Transl Oncol; 2015 Oct; 17(10):795-802. PubMed ID: 26115738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
    Sieger S; Jiang S; Schönsiegel F; Eskerski H; Kübler W; Altmann A; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):748-56. PubMed ID: 12541134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor.
    Li W; Venkataraman GM; Ain KB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1080-7. PubMed ID: 17164311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus.
    Lee WW; Lee B; Kim SJ; Jin J; Moon DH; Lee H
    Oncol Rep; 2003; 10(4):845-9. PubMed ID: 12792733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
    Tan J; Li W; Wang P
    Chin J Cancer; 2011 Aug; 30(8):574-80. PubMed ID: 21801606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification and functional characterization of MUC1 promoter and gene-virotherapy via a targeting adenoviral vector expressing hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cells in vitro.
    Chen L; Liu Q; Qin R; Le H; Xia R; Li W; Kumar M
    Int J Mol Med; 2005 Apr; 15(4):617-26. PubMed ID: 15754023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells.
    Guo R; Zhang Y; Liang S; Xu H; Zhang M; Li B
    Nucl Med Commun; 2010 Oct; 31(10):916-21. PubMed ID: 20683361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
    Liu RS; Hsieh YJ; Ke CC; Chen FD; Hwu L; Wang FH; Hwang JJ; Chi CW; Lee CH; Yeh SH
    Anticancer Res; 2009 Jan; 29(1):211-21. PubMed ID: 19331152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.